ConductScience.org, home

Disease · HP_0002018

Comparisons in its trials33

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

ComparisonGroup 1, with the outcomeGroup 2, with the outcomeParticipantsTrialSource
NP101 Patch vs Placebo Patch: serious adverse events0 of 2340 of 235469NCT00724815Trial comparisons
NP101 Patch vs Placebo Patch: Photophobia Free at Two Hours116 of 22683 of 228454NCT00724815Trial comparisons
NP101 Patch vs Placebo Patch: Pain Free at Two Hours40 of 22621 of 228454NCT00724815Trial comparisons
NP101 Patch vs Placebo Patch: Nausea Free at Two Hours189 of 226144 of 228454NCT00724815Trial comparisons
NP101 Patch vs Placebo Patch: Phonophobia Free at Two Hours125 of 22689 of 228454NCT00724815Trial comparisons
Ginger vs Placebo: Occurrence of Intra-operative and Post-operative Vomiting30 of 11645 of 123239NCT01733212Trial comparisons
Ginger vs Placebo: deaths from any cause0 of 1160 of 123239NCT01733212Trial comparisons
Ginger vs Placebo: serious adverse events0 of 1160 of 123239NCT01733212Trial comparisons
Bevacizumab Before Chemotherapy vs Bevacizumab With Chemotherapy: Objective Response Rate65 of 11566 of 115230NCT01718873Trial comparisons
Bevacizumab Before Chemotherapy vs Bevacizumab With Chemotherapy: deaths from any cause2 of 1152 of 115230NCT01718873Trial comparisons
Bevacizumab Before Chemotherapy vs Bevacizumab With Chemotherapy: Disease Control Rate107 of 115103 of 115230NCT01718873Trial comparisons
Bevacizumab Before Chemotherapy vs Bevacizumab With Chemotherapy: serious adverse events65 of 11575 of 115230NCT01718873Trial comparisons
Bevacizumab Before Chemotherapy vs Bevacizumab With Chemotherapy: Toxic Effects108 of 114113 of 115229NCT01718873Trial comparisons
Ketorolac Group vs IV Meloxicam Group: Length of Stay as Measured by Same Day Discharges23 of 11410 of 109223NCT05291598Trial comparisons
Ketorolac Group vs IV Meloxicam Group: deaths from any cause0 of 1140 of 109223NCT05291598Trial comparisons
Ketorolac Group vs IV Meloxicam Group: serious adverse events0 of 1140 of 109223NCT05291598Trial comparisons
Intrathecal Hydromorphone vs Intrathecal Morphine: Nausea28 of 6632 of 68134NCT02789410Trial comparisons
Intrathecal Hydromorphone vs Intrathecal Morphine: deaths from any cause0 of 660 of 68134NCT02789410Trial comparisons
Intrathecal Hydromorphone vs Intrathecal Morphine: Pruritus27 of 6628 of 68134NCT02789410Trial comparisons
Intrathecal Hydromorphone vs Intrathecal Morphine: serious adverse events0 of 660 of 68134NCT02789410Trial comparisons

diseases-2026-09-18-0.1.0

Sources 6

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/diseases/v1/HP_0002018/comparisons